AEON Biopharma Inc.

About AEON Biopharma Inc.

AEON Biopharma is dedicated to unlocking the potential of therapeutic neurotoxins to treat various nervous system-related conditions. Their mission is to provide lasting relief to millions of patients through innovative formulations and bold treatment paradigms, while offering unique opportunities to providers and payors.

Products & Services

ABP-450 (prabotulinumtoxinA):A lead candidate in their pipeline, aimed at improving the lives of patients with nerve and muscle-based disorders such as migraines and cervical dystonia.

Specialties

Therapeutic Neurotoxins Botulinum Toxin Formulations Treatment of Migraines Treatment of Cervical Dystonia Nerve and Muscle-based Disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: PIPE and Private Placement T: - FT: PIPE and Private Placement	A: 22000000 MR: - FA: up to ~$22 million FAN: 22000000	D: 2025-11-13 FD: 2025-11-13	2 investors
2	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 20000000 MR: - FA: $20.0 million FAN: 20000000	D: 2025-01-07 FD: 2025-01-07	1 investors
3	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 20000000 MR: - FA: approximately $20.0 million FAN: 20000000	D: 2025-01-06 FD: 2025-01-06	1 investors
4	RT: Private Placement of Senior Secured Convertible Notes T: - FT: Private Placement of Senior Secured Convertible Notes	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2024-03-19 FD: 2024-03-19	1 investors
5	RT: Equity Financing T: - FT: Equity Financing	A: 20000000 MR: - FA: at least $20 million FAN: 20000000	D: 2023-01-10 FD: 2023-01-10	1 investors

PIPE and Private Placement Latest

2025-11-13

$22.0M

2 investors (Pro only)

Underwritten Public Offering 2025-01-07

$20.0M

Underwritten Public Offering 2025-01-06

$20.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rob Bancroft

President & CEO, Board Member

A

Alex Wilson

EVP, Chief Legal Officer & Secretary

C

Chad Oh

Chief Medical Officer

J

Jennifer Sy

Chief Accounting Officer

J

Jost Fischer

Chairman and Board Member

E

Eric Carter

Board Member

View 9 more team members with Pro

Unlock Full Team Directory

Recent News